Clinical Trial Update: Study of JMKX003948 Ophthalmic Suspension in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for JMKX003948 Ophthalmic Suspension in healthy participants; study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Macular Edema

Drugs mentioned

• JMKX003948 Ophthalmic Suspension

Snippet

Sponsor: Jemincare | Conditions: Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME) | Phase 1 | Status: NOT_YET_RECRUITING